Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

Similar documents
Comparison of Biotage Extrahera vs. Manual Sample Processing Using a Vacuum Manifold

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

Analytes. Sample Preparation Procedure. Introduction. Format: Sample Pre-treatment. Sample Loading. Analyte Extraction and Derivatization.

Extraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Step 3: muscle, nasal sprays and drops or used as topical

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Dienes Derivatization MaxSpec Kit

Mass Directed Flash Chromatography by Biotage. Biotage Dalton Mass Detectors

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

[ APPLICATION NOTE ] Oasis PRiME HLB Cartridge for Cleanup of Infant Formula Extracts Prior to UPLC-MS/MS Multiresidue Veterinary Drugs Analysis

LC-MS/MS Method for the Determination of Tenofovir from Plasma

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Determination of Amantadine Residues in Chicken by LCMS-8040

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Integration of steroids analysis in serum using LC-MS/MS with full-automated sample preparation

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Vitamin D3 and related compounds by ESI and APCI

Fast quantitative Forensic Analysis of THC and its Metabolites in Biological Samples using Captiva EMR- Lipid and LC/MSMS

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Performance of an ultra low elution volume 96-well plate

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

The use of mobile-device data to better estimate dynamic population size for wastewater-based epidemiology

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Application Note. Author. Abstract. Introduction. Food Safety

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Meeting Challenging Requirements for the Quantitation of Regulated Growth Promoters Dexamethasone and Betamethasone in Liver and Milk

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Improved Isolation and Analysis of Mycotoxins from Cereals, Beer and Wine

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

Protein Precipitation for Biological Fluid Samples Using Agilent Captiva EMR Lipid 96-Well Plates

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Dayana Argoti, Kerry Hassell, Sarah J. Fair, and Joseph Herman Thermo Fisher Scientific, Franklin, MA, USA

Development of a High Sensitivity SPE-LC-MS/MS Assay for the Quantification of Glucagon in Human Plasma Using the ionkey/ms System

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Determination of Patulin in Apple Juice Using SPE and UHPLC-MS/MS Analysis

Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Rapid Analysis of Bisphenols A, B, and E in Baby Food and Infant Formula Using ACQUITY UPLC with the Xevo TQD

Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Author. Introduction. Small Molecule Pharmaceuticals & Generics

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

Quantitative Analysis of Amphetamine-Type Drugs by Extractive Benzoylation and LC/MS/MS. Application. Introduction. Authors. Abstract.

Simultaneous Analysis of Intact Human Insulin and Five Analogs in Human Plasma Using μelution SPE and a CORTECS UPLC Column

Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms

Cannabinoid Quantitation Using an Agilent 6430 LC/MS/MS

Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

PosterREPRINT SIMULTANEOUS QUANTIFICATION OF PSYCHOTHERAPEUTIC DRUGS IN HUMAN PLASMA BY TANDEM MASS SPECTROMETRY

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Author. Introduction. Abstract

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Determination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety

Application Note. Abstract. Authors. Pharmaceutical

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

[ APPLICATION NOTE ] UPLC-MS/MS Analysis of 45 Amino Acids Using the Kairos Amino Acid Kit for Biomedical Research INTRODUCTION APPLICATION BENEFITS

Measuring Lipid Composition LC-MS/MS

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Key Advantages of Comprehensive Cannabis Analysis

Comparison of a UPLC Method across Multiple UHPLC Systems

Rapid and Robust Detection of THC and Its Metabolites in Blood

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Transcription:

Application Note AN842.V. Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis This application note describes the extraction of 25-hydroxy vitamin D from serum, prior to LC-MS/MS analysis. Sample Preparation Procedure Format: ISOLUTE PLD+ Protein and Phospholipid Removal plate, part number 98-0050-P0 Sample Pre-treatment Add 0 µl of ISTD (equivalent to 30 ng/ml) to the serum sample. Mix. Allow to stand for ~ hour for binding to occur. Solvent Application Apply 400 µl of Acetonitrile (MeCN) to each well of the ISOLUTE PLD+ plate. Sample Application Add 00 µl of serum with ISTD and mix thoroughly via repeat aspirate/dispense steps. Analyte Elution Apply vacuum -0.2 bar or 3 psi positive pressure for approximately 5 minutes. For highly particulate laden samples increased pressure or vacuum conditions may be required. Figure. Structures of 25-hydroxy Vitamin D. Introduction ISOLUTE PLD+ Protein and Phospholipid Removal plates offer a substantial improvement in extract cleanliness compared to traditional protein precipitation techniques for bioanalytical sample preparation. This application note describes a simple, effective ISOLUTE PLD+ protocol for the extraction of 25-hydroxy vitamin D from serum, demonstrating high, reproducible analyte recoveries with low protein and phospholipid content in the extracts. Post Extraction Dry the extract in a stream of air or nitrogen using a Biotage SPE Dry (40 C at 40 L/min) or TurboVap (40 C at.0 bar). Reconstitution Apply 00 µl of 30/70 2 mm Ammonium Formate, 0.% formic acid aq/meoh. Dispense crash solvent Dispense sample matrix (e.g. plasma, blood) Apply low vacuum/ positive pressure Analytes 25-hydroxy vitamin D2, 25-hydroxy vitamin D3 and d6-25- hydroxy vitamin D3 as the internal standard. Precipitated proteins retained by depth filter Phospholipids retained Depth Filter Upper Frit Phospholipid Scavenger Sorbent Lower Frit Mix as required Phospholipids Protein Analyte(s) Collect purified analytes Figure 2. Typical ISOLUTE PLD+ procedure

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 2 UPLC Conditions Instrument Waters Acquity UPLC (Waters Assoc., Milford, MA, USA) Column ACE EXCEL 2 C8-PFP, 00 mm x 2. mm id 2 μm, (ACT, UK) Mobile Phase A: 2 mm ammonium formate/0.% formic acid (aq) B: 2 mm ammonium formate/0.% formic acid/meoh Flow Rate 0.4 ml/min Table. UPLC Gradient Conditions. Time %A %B Curve 0 25 75 3 0 00 6 4 25 75 Curve : Conditions in line initiated immediately once time passed. i.e. 25:75 resumed at 4 minutes. Curve 6: Linear Gradient Injection Volume 5 μl (partial loop with overfill) Sample Temperature 20 C Column Temperature 40 C Note: alternative UPLC conditions may be suitable. Check for good chromatographic separation of isobaric interferences to ensure accurate analyte quantitation Mass Spectrometry Conditions Instrument Quattro Premier XE triple quadrupole mass spectrometer (Waters Assoc., Manchester, UK) equipped with an electrospray interface for mass analysis Desolvation Temperature 450 C Ion Source Temperature 50 C Collision Cell Pressure 3.76 e -3 mbar Positive ions acquired in the multiple reaction monitoring (MRM) mode: Table 2. Quattro Premier XE MRM parameters (Qualifier ion details shown in parenthesis). Analyte MRM Transition Cone V Collision Energy ev 25-OH D 2 395.5 > 269.5 (395.5 > 9.2) 25-OH D 3 383.5 > 257.5 (383.5 > 07.2) Results Chromatography Good chromatographic separation of 25-hydroxy vitamin D2 and D3 was achieved in less than 3 minutes, as shown in Figure 3. 30 30 8 26 7 25 d6-25-oh D 3 389.6 > 263.5 30 6 Figure 3. Chromatographic separation of 25-hydroxy vitamin D2 and D3 from Chromsystems calibrated serum at 4.8 and 9.6 ng/ml respectively. ISTD at 30 ng/ml.

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 3 Recovery Serum and stripped serum was spiked at various concentrations from 2 00 ng/ml. High reproducible recoveries > 70% with corresponding RSDs < 0% were demonstrated. Typical recovery data is shown in Figure 4. Chromsystems Calibration Curves Curves were also generated using calibrated serum standards (obtained from Chromsystems) spiked at concentrations from 0 69 ng/ml. Good coefficients of determination were obtained for 25-hydroxy vitamin D2 and D3 (r 2 > 0.99). Figure 4. Recovery profile for 25-hydroxy vitamin D extracted at 50 ng/ml. Figure 7. Chromsystems Calibrated Serum Curve for 25-OH vitamin D2 constructed from 4-69 ng/ml. PBS/BSA Calibration Curves Calibration curves were generated using PBS/BSA spiked at concentrations from 00 ng/ml. Good coefficients of determination were obtained for 25-hydroxy vitamin D2 and D3 (r 2 > 0.99). Figure 5. PBS/BSA Calibration Curve for 25-OH vitamin D2 constructed from 00 ng/ml. Figure 8. Chromsystems Calibrated Serum Curve for 25-OH vitamin D3 constructed from 0-58 ng/ml. Figure 6. PBS/BSA Calibration Curve for 25-OH vitamin D3 constructed from 00 ng/ml.

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 4 DEQAS External Quality Assessment Scheme Final method testing was performed for 5 DEQAS serum samples extracted alongside the Chromsystems calibrators using the optimized method. The DEQAS criteria for acceptable performance is that at least 80% of results should fall within + or - 25% of the All Laboratory Trimmed Mean. Method performance is shown in Table 3. Units are quoted as ng/ml. All values fall within the accepted criteria. Ordering Information Part Number Description Quantity 98-0050-P0 ISOLUTE PLD+ Fixed Well Plate 2-9600 Biotage VacMater TM -96 Sample Processing Manifold PPM-96 Biotage PRESSURE+ 96 Positive Pressure Manifold Table 3. DEQAS 25-OH vitamin D results obtained using optimum method. DEQAS Sample I.D. DEQAS LC/MS Mean 45 2.9 4.5 452 46.7 49. 453 26.6 28.9 454 2.4 25.3 455 22.2 23.7 ISOLUTE PLD+ SD-9600-DHS-EU Biotage SPE Dry Sample Concentrator System 220/240 V SD-9600-DHS-NA Biotage SPE Dry Sample Concentrator System 00/20 V C03263 TurboVap 96, Evaporator 00/20V C03264 TurboVap 96, Evaporator 220/240V Additional Notes Buffer Preparation. 2 mm ammonium formate/0.% formic acid (aq): Weigh 0.262 g and dissolve in H 2O. Add ml of formic acid and make up to L in H 2O. 2. 2 mm ammonium formate/0.% formic acid/meoh: Weigh 0.262 g and dissolve in MeOH. Add ml of formic acid and make up to L in MeOH. Processing Conditions Positive Pressure: Process at approximately 3 psi. Vacuum Processing: Process at approximately -0.2 bar.

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 5 Appendix Biotage Extrahera TM Settings The method described in this application note was automated on the Biotage Extrahera, using ISOLUTE PLD+ Protein and Phospholipid Removal plates. Method performance was comparable. This appendix contains the software settings required to configure Extrahera to run this method. An importable electronic copy of this method for Extrahera can be downloaded from www.biotage.com Biotage Extrahera TM Data Analyte Recovery (n=8) at 50 ng/ml 25-OH Vitamin D2 25-OH Vitamin D3 92.0 8. %RSD 4.0 7.4 Linearity (r 2 ) 0.999 0.999 LLOQ <4 ng/ml <4 ng/ml Method name: AN842 Biotage Extrahera TM 25OH Vit D PLD+ Sample plate/rack: 2 ml sample plate, 96 Extraction Media: ISOLUTE PLD+ plate Screenshot Settings Sample Tab Sample Type: PPT/PLD Sample Starting Sample Volume (µl): 0 Method Comment: Transfer 00 µl of plasma to a PLD plate containing 400 µl acetonitrile. A 00 µl volume is mixed 5 times before a 0.4 bar pressure is applied for 5 minutes

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 6 Screenshot Settings Solvent Load Dispose tips Activated No Solvent Acetonitrile Volume (µl) 400 Collection Activated Volume (µl) 00 Premix Yes Number of times 3 Mix number of times 5 Mix volume (µl) 00 Wait time (min) 0 Pressure (bar) 0.4 Positive pressure time (s) 300 Collect in position A

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 7 Solvent Properties Solvent Description Acetonitrile 2 3 4 5 6 7 8 9 0 Solvent 2 3 4 5 6 7 8 9 0 Reservoir type Refillable Non Refillable Capacity N/A Aspiration flow rate (ml/min) 0 Dispense flow rate (ml/min) 20 Lower air gap flow rate (ml/min) 20 Lower air gap volume (µl) 5 Upper air gap flow rate (ml/min) 20 Upper air gap volume (µl) 00 Upper air gap dispense pause 300 Conditioning? Yes Conditioning number of times 2 Conditioning flow rate (ml/min) 20 Chlorinated Serial dispense No No

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 8 Screenshot Sample Screen Sample name Sample description PLD/PPT Sample PLD/PPT Sample Aspiration flow rate (ml/min) 50 Dispense flow rate (ml/min) 220 Lower air gap flow rate (ml/min) 20 Lower air gap volume (µl) 5 Upper air gap flow rate (ml/min) 20 Upper air gap volume (µl) 700 Upper air gap dispense pause 000 Extraction Media Screen Name ISOLUTE PLD+ Manufacturer Part number Biotage 98-0050-P0 Sorbent load (mg) 0 Capacity volume (µl) 0 Format 96 Comment N/A Solvent dispensation height (mm) -35.0 Sample dispensation height (mm) -35.0 Aspiration height (mm) -5.0 Sample Plate/Rack Screen Name 2 ml Sample Plate, 96 Capacity volume (µl) 800 Format 96 Aspiration height (mm) -62.0 Pre-treatment dispensation height (mm) -28.0

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE PLD+ Prior to LC-MS/MS Analysis Page 9 Pipette tip Screen Name Manufacturer 000 µl Biotage Tip Biotage Part number 444 Capacity (µl) 000 Length (mm) 95 Additional Comments In this application the ISOLUTE PLD+ extraction media default setting are edited such that the tip mixes the very top 00 µl of the 500 µl mixture. If the default ISOLUTE PLD+ settings are used there is a greater risk of tip blockage during mixing. EUROPE Main Office: +46 8 565900 Toll Free: +800 8 56570 Fax: +46 8 59922 Order Tel: +46 8 56570 Order Fax: +46 8 565705 order@biotage.com Support Tel: +46 8 56 59 Support Fax: + 46 8 56 57 eu--pointsupport@biotage.com NORTH & LATIN AMERICA Main Office: + 704 654 4900 Toll Free: + 800 446 4752 Fax: + 704 654 497 Order Tel: + 704 654 4900 Order Fax: + 434 296 827 ordermailbox@biotage.com Support Tel: + 800 446 4752 Outside US: + 704 654 4900 us--pointsupport@biotage.com JAPAN Tel: +8 3 5627 323 Fax: +8 3 5627 32 jp_order@biotage.com jp--pointsupport@biotage.com CHINA Tel: +86 2 2898 6655 Fax: +86 2 2898 653 cn_order@biotage.com cn--pointsupport@biotage.com To locate a distributor, please visit our website www.biotage.com Part Number: AN842.V. 205 Biotage. All rights reserved. No material may be reproduced or published without the written permission of Biotage. Information in this document is subject to change without notice and does not represent any commitment from Biotage. E&OE. A list of all trademarks owned by Biotage AB is available at www.biotage.com/legal. Other product and company names mentioned herein may be trademarks or registered trademarks and/or service marks of their respective owners, and are used only for explanation and to the owners benefit, without intent to infringe.